胶质母细胞瘤代谢病灶的多组学分析揭示复杂的瘤内基因组进化与二肽酶-1驱动的血管增生
研究利用先进神经外科与脑肿瘤影像技术,从胶质母细胞瘤中精准分离自体低代谢与高代谢病灶,行全基因组、外显子组、转录组及影像分析。发现高代谢病灶起源于低代谢病灶,具局灶性扩增与缺失及APOBEC3活性升高,二肽酶1为高代谢病灶新型血管内皮尖端标志物。
要点
- 高代谢病灶起源于低代谢病灶,伴局灶性扩增/缺失和APOBEC3活性升高。
- 二肽酶1是高代谢病灶的新型血管内皮尖端标志物。
- 二肽酶1通过调节转运体活性促进血管生成和肿瘤代谢。
核心结论
- 高代谢病灶与更高频率的基因组异常相关,二肽酶1成为高代谢病灶的新型诊断和预后血管标志物。
- 本研究强调具有诊断意义的空间基因组进化,并阐明开发新型治疗策略的挑战与机遇。
研究设计与样本
- 利用先进神经外科和脑肿瘤影像技术,从胶质母细胞瘤中精准分离自体的低代谢和高代谢病灶。
- 对分离病灶进行全基因组、外显子组、转录组和影像学综合分析。
主要发现
- 高代谢病灶起源于低代谢病灶,表现出策略性局灶性扩增和缺失,以及APOBEC3活性升高。
- 二肽酶1被确定为胶质母细胞瘤高代谢病灶的新型血管内皮尖端标志物。
- 二肽酶1通过调节转运体活性促进血管生成和肿瘤代谢。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Glioblastoma undergoes a complex and dynamic evolution involving genetic and epigenetic changes. Understanding the mechanisms underlying this evolution is vital for the development of efficient therapeutic strategies. Although treatment resistance is associated with intratumoral heterogeneity in glioblastoma, it remains uncertain whether hypometabolic and hypermetabolic lesions observed through clinical positron emission tomography (PET) imaging are influenced by spatial intratumoral genomic evolution. METHODS: In this study, we precisely isolated autologous hypometabolic and hypermetabolic lesions from glioblastoma using advanced neurosurgical and brain tumor imaging technologies, followed by comprehensive whole-genome, exome, transcriptome, and imaging analyses. RESULTS: Our findings unveil that hypermetabolic lesions, originating from hypometabolic lesions, exhibit strategic focal amplifications and deletions, and heightened APOBEC3 activity. Furthermore, we identify dipeptidase 1 as a novel vascular endothelial tip marker for hypermetabolic lesions in glioblastoma, facilitating angiogenesis and tumor metabolism by regulating transporter activities. CONCLUSIONS: Hypermetabolic lesions are associated with a higher frequency of genomic abnormalities and dipeptidase 1 emerges as a novel diagnostic and prognostic vascular marker for hypermetabolic lesions. This study underscores a spatial genomic evolution with diagnostic implications and elucidates challenges and opportunities crucial for the development of novel therapeutic strategies.
引用
- Anand A, Petersen JK, Andersen LVB, et al. Multiomic profiling of glioblastoma metabolic lesions reveals complex intratumoral genomic evolution and dipeptidase-1-driven vascular proliferation. Neuro Oncol. 2025. PMID: 40319462. doi:10.1093/neuonc/noaf071
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。